Radiat Oncol J.
2023 Mar;41(1):12-22. 10.3857/roj.2022.00353.
Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases
- Florez MA1
- De B1
- Chapman BV1
- Prayongrat A1
- Thomas JG2
- Beckham TH1
- Wang C1
- Yeboa DN1
- Bishop AJ1
- Briere T3
- Amini B4
- Li J1
- Tatsui CE2
- Rhines LD2
- Ghia AJ
1
- Affiliations
-
- 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 2Department of Neurological Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 4Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- KMID: 2540750
- DOI: http://doi.org/10.3857/roj.2022.00353
Abstract
- Purpose
There has been limited work assessing the use of re-irradiation (re-RT) for local failure following stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conventionally-fractionated external beam radiation (cEBRT) for salvage therapy following SSRS local failure.
Materials and Methods
We performed a retrospective review of 54 patients that underwent salvage conventional re-RT at previously SSRS-treated sites. Local control following re-RT was defined as the absence of progression at the treated site as determined by magnetic resonance imaging.
Results
Competing risk analysis for local failure was performed using a Fine-Gray model. The median follow-up time was 25 months and median overall survival (OS) was 16 months (95% confidence interval [CI], 10.8–24.9 months) following cEBRT re-RT. Multivariable Cox proportional-hazards analysis revealed Karnofsky performance score prior to re-RT (hazard ratio [HR] = 0.95; 95% CI, 0.93–0.98; p = 0.003) and time to local failure (HR = 0.97; 95% CI, 0.94–1.00; p = 0.04) were associated with longer OS, while male sex (HR = 3.92; 95% CI, 1.64–9.33; p = 0.002) was associated with shorter OS. Local control at 12 months was 81% (95% CI, 69.3–94.0). Competing risk multivariable regression revealed radioresistant tumors (subhazard ratio [subHR] = 0.36; 95% CI, 0.15–0.90; p = 0.028) and epidural disease (subHR = 0.31; 95% CI, 0.12–0.78; p =0.013) were associated with increased risk of local failure. At 12 months, 91% of patients maintained ambulatory function.
Conclusion
Our data suggest that cEBRT following SSRS local failure can be used safely and effectively. Further investigation is needed into optimal patient selection for cEBRT in the retreatment setting.
